Cite
Body mass index and treatment response to subcutaneous abatacept in patients with psoriatic arthritis: a
MLA
Iain B, McInnes, et al. “Body Mass Index and Treatment Response to Subcutaneous Abatacept in Patients with Psoriatic Arthritis: A.” RMD Open, vol. 5, no. 1, Feb. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........cbf9dcccc01b36fba364ba2bb138112e&authtype=sso&custid=ns315887.
APA
Iain B, M., Gianfranco, F., Maria-Antonietta, D., Manuela, L. B., Subhashis, B., Harris A, A., Yedid, E., & Philip J, M. (2019). Body mass index and treatment response to subcutaneous abatacept in patients with psoriatic arthritis: a. RMD Open, 5(1).
Chicago
Iain B, McInnes, Ferraccioli Gianfranco, D’Agostino Maria-Antonietta, Le Bars Manuela, Banerjee Subhashis, Ahmad Harris A, Elbez Yedid, and Mease Philip J. 2019. “Body Mass Index and Treatment Response to Subcutaneous Abatacept in Patients with Psoriatic Arthritis: A.” RMD Open 5 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........cbf9dcccc01b36fba364ba2bb138112e&authtype=sso&custid=ns315887.